News

CAA:CNX

Carrara Exploration (C: CAA) Provides Update on Acquisition of Preveceutical and Private Placement

Spotlight Companies | Equities.com |

​Carrara Exploration Corp.'s (C: CAA) acquisition of PreveCeutical Medical Inc. is expected to close on or about June 15, 2017.


​How PreveCeutical Medical Wants to Own a $3.8 Trillion Industry — Q&A with CEO Stephen Van Deventer

Spotlight Companies | Equities.com |

“An ounce of prevention is worth a pound of cure.”


​PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer

Spotlight Companies | Equities.com |

PreveCeutical Medical Inc. is pleased to announce the appointment of Dr. Harendra (“Harry”) Parekh, Ph.D., BSc., Hons I, as Chief Research Officer (“CRO”).


​PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Extraction, Formulation and Ex Vivo Evaluation of Cannabinoids (“CBD”s) for Delivery via Sol-Gels

Spotlight Companies | Equities.com |

PreveCeutical Medical Inc. (“PMI”) is pleased to announce that it has signed a research and development agreement effective April 22, 2017 (the "Agreement") with UniQuest Pty Limited.


PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Development of Caribbean Blue Scorpion Venom-Derived Natural & Synthetic Peptides

Spotlight Companies | Equities.com |

​PreveCeutical Medical Inc. a health and wellness company, is pleased to announce that it signed a research and option agreement (the "Agreement") with UniQuest Pty Limited.


PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest Pty Limited

Spotlight Companies | Equities.com |

​PreveCeutical Medical Inc. (“PMI”) a health and wellness company, is thrilled to announce that on April 7, 2017, it signed a Letter of Intent (“LOI”) with UniQuest Pty Limited.


​Carrara Exploration (C: CAA) to amalgamate with PreveCeutical in RTO

Spotlight Companies | Equities.com |

Carrara Exploration Corp. (C: CAA) has entered into an amalgamation agreement dated March 21, 2017, with a newly incorporated subsidiary of Carrara (Subco) and PreveCeutical Medical Inc.,


Carrara Exploration (CSE: CAA) signs letter of intent to acquire Preveceutical Medical

Spotlight Companies | Equities.com |

Carrara Exploration Corp. has signed a non-binding letter of intent with PreveCeutical Medical Inc. (PMI)


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

Blockchain in Mobility - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Mobility and Transportation